ranatachykinin a has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, TJ; Alexander, L; Caponigro, G; Engelman, JA; Farsidjani, A; Fleming, M; Goldoni, S; Hammerman, PS; Hao, HX; Kovats, S; LaMarche, MJ; Lim, J; Liu, C; Lu, H; Meyer, MJ; Mohseni, M; Moody, S; Pant, B; Pu, M; Shirley, M; Silver, SJ; Stuart, DD; Velazquez, R; Wang, H; Williams, J | 1 |
1 other study(ies) available for ranatachykinin a and Benign Neoplasms
| Article | Year |
|---|---|
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Mice; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins p21(ras); Signal Transduction; Tachykinins; Xenograft Model Antitumor Assays | 2019 |